BioNTech SE (LON: 0A3M)
London
· Delayed Price · Currency is GBP · Price in USD
114.27
-3.16 (-2.69%)
At close: Jan 22, 2025
BioNTech SE Revenue
BioNTech SE had revenue of 1.24B EUR in the quarter ending September 30, 2024, with 39.04% growth. This brings the company's revenue in the last twelve months to 3.04B, down -54.07% year-over-year. In the year 2023, BioNTech SE had annual revenue of 3.82B, down -77.94%.
Revenue (ttm)
3.04B EUR
Revenue Growth
-54.07%
P/S Ratio
n/a
Revenue / Employee
495.70K EUR
Employees
6,133
Market Cap
22.42B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.82B | -13.49B | -77.94% |
Dec 31, 2022 | 17.31B | -1.67B | -8.78% |
Dec 31, 2021 | 18.98B | 18.49B | 3,834.63% |
Dec 31, 2020 | 482.30M | 373.70M | 344.11% |
Dec 31, 2019 | 108.60M | -18.98M | -14.87% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 221.41B |
AstraZeneca | 38.20B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |